The Proteomic Landscape of CTNNB1 Mutated Low-Grade Early-Stage Endometrial Carcinomas.

Saved in:
Bibliographic Details
Title: The Proteomic Landscape of CTNNB1 Mutated Low-Grade Early-Stage Endometrial Carcinomas.
Authors: Lopez-Janeiro A; Department of Pathology, Clínica Universidad de Navarra, 31008 Pamplona, Spain., Brizzi E; Department of Pathology, Hospital Universitario Puerta del Mar, 11009 Cádiz, Spain., Ruz-Caracuel I; Pathology Department, Hospital Universitario Ramón y Cajal & Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), CIBERONC, 28034 Madrid, Spain., Alexandru R; Department of Pathology, Clínica Universidad de Navarra, 31008 Pamplona, Spain., de Andrea C; Department of Pathology, Clínica Universidad de Navarra, 31008 Pamplona, Spain., Berjón A; Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain.; Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital (IdiPAZ), 28046 Madrid, Spain., Yebenes L; Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain.; Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital (IdiPAZ), 28046 Madrid, Spain., Mendiola M; Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain.; Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital (IdiPAZ), 28046 Madrid, Spain.; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Heredia-Soto V; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain., Montero-Calle A; Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain., Barderas R; Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.; CIBER Frailty and Healthy Aging, 28029 Madrid, Spain., de Los Rios V; Centro de Investigaciones Biológicas, CSIC, 28040 Madrid, Spain., Redondo A; Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain.; Department of Medical Oncology, Hospital Universitario La Paz, 28046 Madrid, Spain.; Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain., Pelaez-Garcia A; Proteomics Unit (UCCTs), Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain., Hardisson D; Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain.; Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital (IdiPAZ), 28046 Madrid, Spain.; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Source: Cells [Cells] 2025 Oct 27; Vol. 14 (21). Date of Electronic Publication: 2025 Oct 27.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2073-4409
DOI:10.3390/cells14211676